Icon times
Aarti Drugs Stock Fundamental Analysis - Financial Results & Equity Research | Investyadnya Stock-o-Meter

Aarti Drugs

CompanyOver

 / 
 
 

About

Highlights

Performing rate for the company

Track the companies of Group.

Relaince Group

Sector: Refineries

Market Price

2,529.50

Market Cap(₹Cr.)

2,529.50

-90.00

Quarterly Results ( Figures in Rs. Crores.)

No Data is available.

Profit & Loss ( Figures in Rs. Crores.)

No Data is available.

Balance Sheet ( Figures in Rs. Crores.)

No Data is available.

Cash Flows ( Figures in Rs. Crores.)

No Data is available.

Historical Growths

Compounded Sales Growth
Compounded Profit Growth
Compounded Expense Growth
Stock Price CAGR
No data is available
Sales Growth Profit Growth Expense Growth Stock Price CAGR

Ratios ()

No Data is available.

Major Shareholders

No Data is available.

Shareholders more than 1%

No Data is available.

Fund houses invested in the stock (Figures in % Equity Capital )

No Data is available.

Corporate Action

No Data is available.
No Data is available.
No Data is available.
No Data is available.

Documents

Presentation & Earning Calls

Annual Reports

Credit Rating

No document is available
No document is available
No document is available
No document is available.

Overview

Aarti Drugs Ltd. with a mission and a vision to strive for excellence and produce the best quality products are standing strong in the pharmaceuticals and chemical market since 1984. The company has a whopping turnover of more than 1500 crores and has a robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations. Their manufacturing units are located at Tarapur and Sarigam in Maharashtra, India. The group is involved in the production of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals, and produces Formulations. Aarti Drugs market cap, with its inherent strengths of timely responses, competitive pricing, firm commitments, and high-quality products, has made a strong reputation. It enabled it to mark a definite global presence with its products exported to over 100 countries worldwide. Over the years, the company has been able to carve a niche for itself and is looking forward to expanding the volumes aiming to become the first choice of their customers. It is listed on both the national and the Bombay stock exchange lists.

 

MERGERS AND ACQUISITIONS

In 1996, The amalgamation of Rupal Chemical Industries Limited, Rashesh Chemicals & Pharmaceuticals Limited, Manjarati Chemicals Private Limited, Manjarati Plasticizer Private Limited, Effective Chemicals Private Limited, Star Aluminium Industries Limited and Avez Wire with AARTI DRUGS made the company stronger.

Aarti drugs LTD. has a fully owned subsidiary known as Pinnacle Life Science Pvt. Ltd as per Aarti Drugs Fundamental Analysis.

They entered into a joint venture with a Chinese company engaged in Active Pharmaceutical Ingredients (APIs) manufacturing and formed Huanggang Yinhe Aarti Pharmaceutical Company Ltd for manufacturing and selling APIs in China.

 

SERVICES

They have API's in the following categories-

  • Anti-inflammatory
  • Cardioprotection
  • Antidiarrheals
  • Antifungals
  • Anti Arthritis/ Osteoporosis
  • Antibiotic
  • Antidiabetic
  • Alzheimer’s treatment
  • Sedative
  • Vitamins
  • Alcoholism Treatment

They also deal in speciality chemicals and pharma intermediates. 

Aarti drugs also has a research and development department and have few products under development.



MILESTONES

In the year 1993, Aarti drugs stock price went public and got listed on the Bombay Stock Exchange list, followed by a listing on the National Stock Exchange of India Limited in 2003.

The company touched their first 100 crore turnover mark in 1998.

In 2008, Aarti drugs received approval for the USFDA Plant.

In the year 2014, Aarti drugs achieved their 1000 crore turnover mark and 100% holdings in Pinnacle Life Science Pvt. Ltd.

The manufacturing units of Aarti Drugs Ltd. are GMP certified. The Company is also in the process of acquiring an ISO 9002 compliance for all its units, and one of the units has already been approved.

AWARDS AND RECOGNITIONS

Aarti drugs were given the business partner of the year award by ABBOTT in 2013, 2015, and from 2015-2018.

GOVERNMENT OF INDIA( MINISTRY OF COMMERCE AND INDUSTRY ) in 2014 gave Aarti Drugs a Certificate of Recognition - Star Export House.

The company was honoured by PHARMEXCIL various times for their Outstanding Performance in exports and Latin American exports.

For two years in a row, 2005 and 2006 Aarti, drugs bagged the award for customer responsiveness by Avaya Global Connect.

They received an award by the ORGANIZATION OF PHARMACEUTICAL PRODUCT for Best Vendor in 2001.

 

ABOUT INVEST YADNYA

Invest Yadnya is an eLearning platform engaged in educating & simplifying the contents based on personal finance for all individuals. We have combined technology with financial planning expertise to assist an individual in meeting their financial objectives. You can find managed portfolios, stock market indicators, investment portfolios, financial planning ebooks, equity research tools, Stock research tools in India, investment portfolios, stock advisors, free stock charts, stock analysis websites at InvestYadnya. If you are really interested in learning about investments and finances, you can check out free books download pdf, a book about finance, income tax books, free stock charts, analysis of financial statements pdf, financial statements analysis pdf, and mutual fund books.

We keep on updating our data & supply the latest information like Aarti Drugs share price. 

We also provide our clients with the Aarti Drugs value research, Aarti Drugs annual report, Aarti Drugs share price history, Aarti drugs PE ratio, Aarti Drugs Fundamentals and Aarti Drugs technical analysis to understand its financial position before making any investment decisions. Aarti Drugs analyst report offers a summary of how it incurs revenues & expenses and the historical growth rate, while Aarti Drugs fundamental analysis help the clients understand their financial position before making any investment decisions. The investors are also able to identify the core values and worth of the company as the details helps them to with Aarti Drugs swot analysis. We also provide the Aarti Drugs financial analysis so that, you get a clear idea of it. Invest confidently and in a secured manner at Invest Yadnya. Create a free account and search for all the details about 950+ companies, including Aarti Drugs limited, with one of the best sites for Indian stock market analysis.

Our website has information about 113 other Pharmaceuticals & Drugs companies that give insight into its financials. Companies include Divis Laboratories, Dr Reddys Laboratories, Cipla, Biocon, Aurobindo Pharma, Lupin, Torrent Pharmaceuticals, Cadila Healthcare, Abbott India, Glaxosmithkline Pharmaceuticals & many more.

 

Brands Of Aarti Drugs

Brands Of Aarti Drugs

undefined

Comment

Chat on WhatsApp
Caret UP Arrow
InvestYadnya Support
Typically replies in minutes
InvestYadnya Support
Hi there
Welcome to InvestYadnya.
We are available to assist you on WhatsApp.
Please click on the button below to chat with us.
(10 AM to 7 PM IST)
16:10
Chat with InvestYadnya